Release date: 2024-08-21 11:06:02 Recommended: 102
Koselugo is a small molecule MEK inhibitor (mitogen activation inhibitor), and its main mechanism of action is to block the growth and proliferation of tumor cells by inhibiting the activation of MEK signaling pathway.
Koselugo is a targeted therapy that specifically intervenes in specific molecular pathways.
Koselugo is an MEK inhibitor that effectively inhibits the growth and proliferation of tumor cells by blocking MEK-1/2, a key enzyme in the MAPK signaling pathway. This mechanism allows Koselugo to show significant efficacy in the treatment of tumors that are not sensitive to traditional chemotherapy, such as low-grade serous ovarian or peritoneal cancer.
Koselugo also plays an important role in the treatment of rare diseases such as neurofibromatosis, especially for patients with inoperable pelvic neurofibromas, Koselugo can reduce symptoms, control disease progression, and significantly improve patients' quality of life. Koselugo is an indispensable and important drug in the treatment of tumors.
Koselugo blocks the growth and proliferation of tumor cells through a unique mechanism of action, has demonstrated significant efficacy in the treatment of tumors targeting specific molecular pathways, and is currently available in multiple versions on the market.
There are multiple versions of Koselugo, including the original drug, the Hong Kong version of the drug, and the generic drug. Different versions of the drug differ in many ways. Here's an overview of the different versions of Koselugo:
The original drug of Koselugo is produced by AstraZeneca in the United Kingdom, and its specifications include 10mg*60 capsules and 25mg*60 capsules, etc., and the price is relatively high, and the price of a box may reach tens of thousands of yuan to hundreds of thousands of yuan.
The specifications of the Hong Kong version of Koselugo also include 10mg*60 capsules and 25mg*60 capsules, but the price is lower than that of the original drug. The price of 10mg*60 capsules of the Hong Kong version of Koselugo may range from 32,500 to 36,400 yuan, while the price of 25mg*60 capsules may range from 85,000 to 89,700 yuan.
The generic version of Koselugo produced by Laos Lucius Pharmaceutical Co., Ltd. has been launched on the market, becoming the world's first generic version. Its specifications include 10mg*60 capsules of Koselugo for 2800 yuan, and 25mg*60 capsules of Koselugo for 5500 yuan.
Among the above versions, the generic version produced by Lucius Pharmaceutical Co., Ltd. is the most popular version in the market.
The generic version of Koselugo produced by Laos Lucius Pharmaceutical Co., Ltd. has two major advantages:
Compared with the original drug, the price of the generic Koselugo of Lucius Pharmaceutical in Laos has been greatly reduced, providing patients with a more affordable treatment option and effectively reducing the financial burden of patients and their families.
The generic drug has undergone a rigorous clinical trial and approval process to ensure that it is similar in efficacy and safety to the original drug. Patients do not need to worry about the efficacy and side effects of generic drugs and can use them with confidence.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.